Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on November 3, 2026

Nov. 3, 2026

Cartesian Therapeutics Announces New Employment Inducement Grant

Indeterminate GlobeNewswire

Nov. 3, 2026

Tango Therapeutics to Participate in Guggenheim’s 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors

Indeterminate GlobeNewswire

Nov. 3, 2026

Pasithea Therapeutics Announces FDA Clearance of IND for PAS-004 in Neurofibromatosis Type 1 (NF1)-Associated Cutaneous Neurofibromas (cNF)

Indeterminate GlobeNewswire

Nov. 3, 2026

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Hemab Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 10, 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Jade Biosciences to Participate in Upcoming Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

BlossomHill Therapeutics to Present at Guggenheim’s 3rd Annual Healthcare Innovations Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Nov. 3, 2026

C4 Therapeutics to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Oruka Therapeutics to Participate in Multiple Upcoming Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Arvinas Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 3, 2026

Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results

Indeterminate GlobeNewswire

Nov. 3, 2026

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November

Indeterminate GlobeNewswire

Nov. 3, 2026

ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Dr. Oetker Launches Fifth Year of Giuseppe Practice with a Pro, Welcomes P.K. Subban as the Program’s New Ambassador

Indeterminate GlobeNewswire

Nov. 3, 2026

Dr. Oetker lance la cinquième édition de Giuseppe Entraîne-toi avec un pro et accueille P.K. Subban comme nouvel ambassadeur

Indeterminate GlobeNewswire

Nov. 3, 2026

Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22%

Indeterminate GlobeNewswire

Nov. 3, 2026

QUANTRO Therapeutics secures key Austrian research grant to build its AI-powered drug discovery platform

Indeterminate GlobeNewswire